CARB-X Investor
Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.
Investor Type:
Donors
Founded Date:
2016-07-01
Employee Number:
11-50
Number Of Exists:
31
Headquarters:
Boston,Massachusetts,United States,North America
Number Of Investments Funding Rounds:
128